TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 91 filers reported holding TG THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 117.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $62,111,000 | +23.8% | 1,601,224 | +53.8% | 0.07% | +13.3% |
| Q1 2021 | $50,189,000 | +30.3% | 1,041,271 | +40.6% | 0.06% | +20.0% |
| Q4 2020 | $38,512,000 | +18326.8% | 740,336 | +9391.5% | 0.05% | – |
| Q3 2020 | $209,000 | -97.7% | 7,800 | -99.4% | 0.00% | -100.0% |
| Q2 2016 | $9,140,000 | +670.7% | 1,215,449 | +753.5% | 0.04% | +620.0% |
| Q1 2016 | $1,186,000 | -30.2% | 142,400 | 0.0% | 0.01% | -28.6% |
| Q4 2015 | $1,699,000 | +19.8% | 142,400 | +1.2% | 0.01% | +16.7% |
| Q3 2015 | $1,418,000 | +17.1% | 140,700 | +102.7% | 0.01% | +20.0% |
| Q2 2015 | $1,211,000 | +76.0% | 69,400 | +40.8% | 0.01% | +66.7% |
| Q1 2015 | $688,000 | – | 49,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |